Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management

R. G. Bretzel, D. Brandhorst, H. Brandhorst, M. Eckhard, W. Ernst, S. Friemann, W. Rau, B. Weimar, K. Rauber, B. J. Hering, M. D. Brendel

Research output: Contribution to journalArticlepeer-review

98 Scopus citations
Original languageEnglish (US)
Pages (from-to)140-143
Number of pages4
JournalJournal of Molecular Medicine
Volume77
Issue number1
DOIs
StatePublished - 1999

Bibliographical note

Funding Information:
Acknowledgements The authors are indebted to the technicians at our islet isolation laboratory, Birte Blöcher, Birgit Janczik and Gudrun Pfeiffer. We also thank Andreas O. Schultz, Ramona Vietzke and Barbara Schultz for running our International Islet Transplant Registry. This work was supported by the Deutsche Forschungsgemein-schaft (He 1503/1–3), Bundesministerium für Forschung und Technologie (FKZ 07024806), Juvenile Diabetes Foundation International, Deutsche Stiftung Organtransplantation, and Eurotransplant Foundation.

Keywords

  • Clinical islet transplantation Type-1 diabetes mellitus
  • Immunosuppression
  • Islet isolation

Cite this